|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 25 MASSACHUSETTS AVENUE, NW |
Address2 | SUITE 600 |
City | WASHINGTON |
State | DC |
Zip Code | 20001 |
Country | USA |
3. Principal place of business (if different than line 2)
City | 330 N. Wabash Avenue, Chicago |
State | IL |
Zip Code | 60611 |
Country | USA |
|
5. Senate ID# 2877-12
|
||||||||
|
6. House ID# 304640000
|
TYPE OF REPORT | 8. Year | 2014 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date | |
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: George E. Cox III |
Date | 07/18/2014 |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code EDU
16. Specific lobbying issues
H.R. 1180, Resident Physician Shortage Reduction Act of 2013, all provisions
S. 577, Resident Physician Shortage Reduction Act of 2013, all provisions
H.R. 3903, Foreign Medical School Accountability Fairness Act of 2014, all provisions
S. 1822, Foreign Medical School Accountability Fairness Act of 2013, all provisions
Graduate Medical Education
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Aiken |
Hackett |
|
|
|
Jason |
Marino |
|
|
|
Thomas |
Roberge |
|
|
|
Andrew |
Wankum |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
H.R. 1701, Cutting Costly Codes Act of 2013, all provisions
S. 972, Cutting Costly Codes Act of 2013, all provisions
H.R. 3750, Telehealth Modernization Act of 2013, all provisions
H.R. 4341, Truth in Advertising Act of 2014, all provisions
H.R. 2027, Expanding Patients' Access to Quality Care Act of 2013, all provisions
H.R. 4707, To authorize the appropriation of funds to the Centers for Disease Control and Prevention for conducting or supporting research on firearms safety or gun violence prevention, all provisions
S. 2373, A bill to authorize the appropriation of funds to the Centers for Disease Control and Prevention for conducting or supporting research on firearms safety or gun violence prevention, all provisions
Food and Drugs Administration Safety and Innovation Act (FDASIA)
Prescription Drug Abuse and Diversion
DEA Registration and Registration Fees
Telemedicine
Prescription Drug Monitoring Program (PDMP)
ICD-10 Repeal
Prescriber education and mandatory/voluntary CME training
Sunshine Act - Reprints
Meaningful Use of EHRs/Health Information Technology
EHR Patient Safety
Prescription requirements for OTC medications
Continuity of Care
Hydrocodone Rescheduling
Mental health care
Diabetes Prevention
Hospital Consolidation
HIPAA
Follow-on Biologics
Access to care
ACA Implementation
Physician Consortium for Performance Improvement (PCPI)
Compounding
Laboratory developed tests
Genetics
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), Food & Drug Administration (FDA), Federal Communications Commission (FCC), Drug Enforcement Administration (DEA), Office of Natl Drug Control Policy (NDCP), Justice - Dept of (DOJ), White House Office
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Lindsey |
Brill |
|
|
|
Aiken |
Hackett |
|
|
|
Dana |
Lichtenberg |
|
|
|
Jason |
Marino |
|
|
|
Thomas |
Roberge |
|
|
|
Andrew |
Wankum |
|
|
|
Margaret |
Garikes |
|
|
|
Sandy |
Marks |
|
|
|
Sharon |
McIlrath |
|
|
|
Matt |
Reid |
|
|
|
Cybil |
Roehrenbeck |
|
|
|
Koryn |
Rubin |
|
|
|
Mari |
Savickis |
|
|
|
Jason |
Scull |
|
|
|
George |
Cox |
III |
|
|
Eileen |
Carlson |
|
|
|
Debra |
Cohn |
|
|
|
Kristen |
O'Brien |
|
|
|
Sylvia |
Trujillo |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
S. 2552, A bill to enhance beneficiary and provider protections and improve transparency in the Medicare Advantage market, and for other purposes, all provisions
H.R. 1180, Resident Physician Shortage Reduction Act of 2013, all provisions
S. 577, Resident Physician Shortage Reduction Act of 2013, all provisions
H.R. 1701, Cutting Costly Codes Act of 201, all provisions
S. 972, Cutting Costly Codes Act of 2013, all provisions
H.R. 1179, Improving Access to Medicare Coverage Act of 2013, all provisions
S. 569, Improving Access to Medicare Coverage Act of 2013, all provisions
H.R. 4015, SGR Repeal and Medicare Provider Payment Modernization Act of 2014, all provisions
S. 2000, SGR Repeal and Medicare Provider Payment Modernization Act of 2014, all provisions
H.R. 962, Medicare Diabetes Prevention Act of 2013, all provisions
S. 452, Medicare Diabetes Prevention Act of 2013, all provisions
H.R. 1070, Removing Barriers to Colorectal Cancer Screening Act of 2013, all provisions
S. 2348, Removing Barriers to Colorectal Cancer Screening Act of 2014, all provisions
H.R. 3750, Telehealth Modernization Act of 2013, all provisions
H.R. 3698, Two-Midnight Rule Delay Act of 2013, all provisions
S. 1180, Medicare Data Access for Transparency and Accountability Act, all provisions
H.R. 4188, Establishing Beneficiary Equity in the Hospital Readmission Program Act, all provisions
S. 2501, Hospital Readmissions Program Accuracy and Accountability Act of 2014, all provisions
H.R. 4302, Protecting Access to Medicare Act of 2014, provisions relating to the SGR patch
Medicare program - Medicare Advantage
Medicare program - SGR Repeal
Medicare program - ICD-10 Repeal
Medicare program - HIPAA (ICD-10, EFT)
Medicare program - Physician payment and delivery reform issues
Medicare program - Payment for short hospital stays
Medicare program - Quality reporting penalty
Medicare program - Independent Payment Advisory Board (IPAB)
Medicare program - Medicare Patient Empowerment Act
Medicare program - Funding for quality measure development
Medicare program - Claims Data release
Medicare program - Telemedicine
Medicare program - Molecular diagnostics
Medicare program - In-office Ancillary Services Exception
Medicare program - Laboratory payments
Medicare program - Graduate Medical Education
Medicare program - Continuity of Care
Medicare program - Coding Issues (Misvalued Codes and RUC Timeline)
Medicare program - Current Procedural Terminology (CPT)
Medicare program - Two-Midnight Rule
Medicare program - Recovery Audit Contractors (RACs)
Medicare program - Appeals backlog
Medicare program - Program Integrity
Medicare program - EHR Fraud
Medicare program - Nursing home patients' access to Schedule II pain medication
Medicare program - Physician identity theft
Medicare program - Enrollment
Medicare program - Grace period
Medicare program - Exchanges
Medicare program - Smart Cards
Medicare program - Electronic Submission of Medical Documentation (esMD)
Medicare program - Licensure
Medicare program - Part D and Hospice Patients
Medicare program - Physician Compare
Medicare program - Conditions of Participation
Medicare program - Quality resource use reports
Medicare program - Physician Quality Reporting System (PQRS)
Medicare program - Value-based modifier
Medicare program - Narrow networks
Medicare program - Clinician and Group Consumer Assessment of Healthcare Providers and Systems (CG-CAHPS) survey
Medicare and Medicaid programs - Meaningful Use of EHRs/Health Information Technology
Medicare and Medicaid programs - Mental health care
Medicaid program - Parity for primary care physician services
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Health & Human Services - Dept of (HHS), Centers For Medicare and Medicaid Services (CMS), U.S. Secret Service, Medicare Payment Advisory Commission (MedPAC), Government Accountability Office (GAO), Treasury - Dept of, White House Office
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Lindsey |
Brill |
|
|
|
Aiken |
Hackett |
|
|
|
Dana |
Lichtenberg |
|
|
|
Jason |
Marino |
|
|
|
Thomas |
Roberge |
|
|
|
Andrew |
Wankum |
|
|
|
Margaret |
Garikes |
|
|
|
Sandy |
Marks |
|
|
|
Sharon |
McIlrath |
|
|
|
Matt |
Reid |
|
|
|
Cybil |
Roehrenbeck |
|
|
|
Koryn |
Rubin |
|
|
|
Mari |
Savickis |
|
|
|
George |
Cox |
III |
|
|
Eileen |
Carlson |
|
|
|
Debra |
Cohn |
|
|
|
Kristen |
O'Brien |
|
|
|
Sylvia |
Trujillo |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TOB
16. Specific lobbying issues
2015 Youth Tobacco Survey
Exempting cigars from FDA regulation
17. House(s) of Congress and Federal agencies Check if None
Centers For Disease Control & Prevention (CDC), U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
George |
Cox |
III |
|
|
Debra |
Cohn |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TOR
16. Specific lobbying issues
H.R. 1473, Standard of Care Protection Act of 2013, all provisions
S. 1769, Standard of Care Protection Act, all provisions
H.R. 1733, Good Samaritan Health Professionals Act of 2013, all provisions
S. 2196, Good Samaritan Health Professionals Act of 2014, all provisions
H.R. 3722, To provide protections for certain sports medicine professionals who provide certain medical services in a secondary State, all provisions
S. 2220, A bill to provide protections for certain sports medicine professionals who provide certain medical services in a secondary State, all provisions
Medical Liability Reform
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Aiken |
Hackett |
|
|
|
Jason |
Marino |
|
|
|
Thomas |
Roberge |
|
|
|
Andrew |
Wankum |
|
|
|
George |
Cox |
III |
|
|
Kristen |
O'Brien |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code VET
16. Specific lobbying issues
S. 2450, Veterans' Access to Care through Choice, Accountability, and Transparency Act of 2014, all provisions
H.R. 3230, Veterans' Access to Care through Choice, Accountability, and Transparency Act of 2014, all provisions
House Committee on Appropriations Report 113-416 accompanying H.R. 4486, the Military Construction and Veterans Affairs Related Agencies Appropriations Act, 2015, provisions relating to draft Veterans Health Administration Nursing Handbook
H.R. 4810, Veteran Access to Care Act of 2014, all provisions
Veterans' Affairs Reform
TRICARE
Scope of Practice
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, President of the U.S.
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Lindsey |
Brill |
|
|
|
Aiken |
Hackett |
|
|
|
Jason |
Marino |
|
|
|
Thomas |
Roberge |
|
|
|
Andrew |
Wankum |
|
|
|
Margaret |
Garikes |
|
|
|
Cybil |
Roehrenbeck |
|
|
|
George |
Cox |
III |
|
|
Eileen |
Carlson |
|
|
|
Debra |
Cohn |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
House Committee on Appropriations Report 113-416 accompanying H.R. 4486, the Military Construction and Veterans Affairs Related Agencies Appropriations Act, 2015, provisions relating to draft Veterans Health Administration Nursing Handbook
FY 2015 Labor-HHS- Education Appropriations bill, provisions relating to pediatric subspecialty loan repayment program
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Jason |
Marino |
|
|
|
George |
Cox |
III |
|
|
Eileen |
Carlson |
|
|
|
Debra |
Cohn |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code LBR
16. Specific lobbying issues
Medical Licensure
Follow-on Biologics
Antitrust
Hospital Consolidation
Health care competition
17. House(s) of Congress and Federal agencies Check if None
Federal Trade Commission (FTC), Government Accountability Office (GAO)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Lindsey |
Brill |
|
|
|
Margaret |
Garikes |
|
|
|
Cybil |
Roehrenbeck |
|
|
|
George |
Cox |
III |
|
|
Eileen |
Carlson |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address | |
||||||
City | |
State | |
Zip Code | |
Country | |
21. Client new principal place of business (if different than line 20)
City | |
State | |
Zip Code | |
Country | |
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
5 |
|
||||||
2 |
|
6 |
|
||||||
3 |
|
7 |
|
||||||
4 |
|
8 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
TAX |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 3 | 5 |
2 | 4 | 6 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 5 | 9 |
2 | 6 | 10 |
3 | 7 | 11 |
4 | 8 | 12 |